Protagonist Therapeutics, Inc (PTGX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.15B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-828.00K; Retained Earnings (Accumulated Deficit)USD $-304.04M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.12B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-269.00K; Retained Earnings (Accumulated Deficit)USD $-466.89M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.08B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $641.00K; Retained Earnings (Accumulated Deficit)USD $-470.67M.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.07B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $525.00K; Retained Earnings (Accumulated Deficit)USD $-426.29M.
Protagonist Therapeutics, Inc Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Preferred Stock, Value, Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K | $1.15B | $-828.00K | $-304.04M | $841.54M | (m) | 3 month · $14.04M 6 month · $28.56M | (m) | (m) |
| 2026-03-31 | $1.00K | $1.12B | $-269.00K | $-466.89M | $655.47M | (m) | 3 month · $14.52M | (m) | (m) |
| 2025-12-31 | $1.00K | $1.08B | $641.00K | $-470.67M | $614.71M | (m) | 12 month · $45.97M | (m) | (m) |
| 2025-09-30 | $1.00K | $1.07B | $525.00K | $-426.29M | $645.44M | (m) | 3 month · $10.56M 9 month · $35.27M | (m) | (m) |
| 2025-06-30 | $1.00K | $1.05B | $-15.00K | $-386.95M | $668.02M | (m) | 3 month · $10.91M 6 month · $24.71M | (m) | (m) |
| 2025-03-31 | $1.00K | $1.04B | $85.00K | $-352.18M | $689.05M | (m) | 3 month · $13.80M | (m) | (m) |
| 2024-12-31 | $1.00K | $1.02B | $-82.00K | $-340.52M | $675.29M | (m) | 12 month · $37.55M | (m) | (m) |
| 2024-09-30 | $1.00K | $1.00B | $1.34M | $-472.20M | $531.91M | (m) | 3 month · $10.16M 9 month · $28.46M | (m) | (m) |
| 2024-06-30 | $1.00K | $980.56M | $-249.00K | $-438.99M | $541.32M | (m) | 3 month · $8.94M 6 month · $18.30M | (m) | (m) |
| 2024-03-31 | $1.00K | $969.04M | $-229.00K | $-408.37M | $560.44M | (m) | 3 month · $9.35M | (m) | (m) |
| 2023-12-31 | $1.00K | $952.49M | $-105.00K | $-615.71M | $336.68M | (m) | 12 month · $29.29M | 12 month · $33.81M | (m) |
| 2023-09-30 | $1.00K | $945.36M | $-170.00K | $-643.04M | $302.15M | (m) | 3 month · $6.76M 9 month · $22.69M | 3 month · $33.81M 9 month · $33.81M | (m) |
| 2023-06-30 | $1.00K | $903.21M | $-198.00K | $-608.94M | $294.07M | (m) | 3 month · $-8.34M 6 month · $15.93M | (m) | (m) |
| 2023-03-31 | $1.00K | $786.77M | $-122.00K | $-570.48M | $216.17M | (m) | 3 month · $7.58M | (m) | (m) |
| 2022-12-31 | (m) | $752.72M | $-359.00K | $-536.75M | $215.61M | 12 month · $25.00K | 12 month · $24.20M | (m) | (m) |
| 2022-09-30 | (m) | $746.66M | $-480.00K | $-502.56M | $243.62M | 9 month · $25.00K | 3 month · $5.95M 9 month · $18.69M | (m) | (m) |
| 2022-06-30 | (m) | $740.03M | $-720.00K | $-471.33M | $267.98M | 3 month · $25.00K 6 month · $25.00K | 3 month · $6.80M 6 month · $12.74M | (m) | (m) |
| 2022-03-31 | (m) | $732.54M | $-472.00K | $-430.29M | $301.78M | (m) | 3 month · $5.93M | (m) | (m) |
| 2021-12-31 | (m) | $709.68M | $-299.00K | $-409.36M | $300.02M | (m) | 12 month · $16.39M | (m) | (m) |
| 2021-09-30 | (m) | $702.32M | $-204.00K | $-372.45M | $329.66M | (m) | 3 month · $4.78M 9 month · $11.37M | (m) | (m) |
| 2021-06-30 | (m) | $696.16M | $-59.00K | $-338.65M | $357.45M | (m) | 3 month · $3.94M 6 month · $6.60M | (m) | (m) |
| 2021-03-31 | (m) | $567.18M | $-33.00K | $-307.81M | $259.33M | (m) | 3 month · $2.66M | (m) | (m) |
| 2020-12-31 | (m) | $563.39M | $28.00K | $-283.81M | $279.61M | (m) | 12 month · $7.90M | (m) | (m) |
| 2020-09-30 | (m) | $434.60M | $-88.00K | $-264.93M | $169.59M | (m) | 3 month · $1.89M 9 month · $5.93M | (m) | (m) |
| 2020-06-30 | (m) | $424.86M | $-208.00K | $-257.16M | $167.49M | (m) | 3 month · $2.00M 6 month · $4.04M | (m) | (m) |
| 2020-03-31 | (m) | $300.30M | $107.00K | $-237.74M | $62.67M | (m) | 3 month · $2.05M | (m) | (m) |
| 2019-12-31 | (m) | $297.85M | $-221.00K | $-217.66M | $79.96M | (m) | 12 month · $8.35M | (m) | (m) |
| 2019-09-30 | (m) | $295.67M | $-154.00K | $-200.16M | $95.36M | (m) | 3 month · $2.20M 9 month · $6.19M | (m) | (m) |
| 2019-06-30 | (m) | $268.23M | $-167.00K | $-183.75M | $84.32M | (m) | 3 month · $2.01M 6 month · $3.99M | (m) | (m) |
| 2019-03-31 | (m) | $255.59M | $-189.00K | $-154.58M | $100.83M | (m) | 3 month · $1.98M | (m) | (m) |
| 2018-12-31 | $0.00 | $253.22M | $-233.00K | $-140.47M | $112.52M | (m) | 12 month · $6.92M | (m) | (m) |
| 2018-09-30 | (m) | $250.67M | $-103.00K | $-126.61M | $123.96M | (m) | 3 month · $2.02M 9 month · $4.85M | (m) | (m) |
| 2018-06-30 | (m) | $225.62M | $-86.00K | $-117.87M | $107.66M | (m) | 3 month · $1.65M 6 month · $2.83M | (m) | (m) |
| 2018-03-31 | (m) | $223.90M | $-72.00K | $-109.21M | $114.62M | (m) | 3 month · $1.19M | (m) | (m) |
| 2017-12-31 | $0.00 | $222.19M | $-6.00K | $-101.55M | $120.63M | (m) | 12 month · $4.24M | (m) | (m) |
| 2017-09-30 | $0.00 | $156.23M | $100.00K | $-98.50M | $57.84M | (m) | (m) | (m) | $0.00 |
| 2017-06-30 | $0.00 | $154.70M | $3.00K | $-93.67M | $61.03M | (m) | (m) | (m) | $0.00 |
| 2017-03-31 | $0.00 | $153.61M | $-22.00K | $-78.69M | $74.89M | (m) | (m) | (m) | $0.00 |
| 2016-12-31 | $0.00 | $152.39M | $-245.00K | $-64.59M | $87.56M | (m) | 12 month · $2.13M | (m) | $0.00 |
| 2016-09-30 | $0.00 | $150.86M | $-24.00K | $-53.34M | $97.49M | (m) | (m) | (m) | (m) |
| 2016-06-30 | $0.00 | $158.00K | $-101.00K | $-46.26M | $-46.20M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $118.00K | $-102.00K | $-27.42M | $-27.40M | (m) | 12 month · $99.00K | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | $-12.62M | (m) | 12 month · $42.00K | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $-1.39M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |